Ruth M. Rothstein CORE Center

Chicago, Illinois 60612

1 studies enrolling now · 18 studies all time

What they study most

Aging, Epstein-Barr Virus-Associated Lymphoma, Fibrosis, HIV, HIV Infection, HIV Infections, HIV-1, Hepatitis C, Hepatitis C Infection, Hepatitis C, Chronic, Hiv, Human Immunodeficiency Virus

Studies at this site

• Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder — Recruiting now
• Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) — Completed
• Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies — Completed
• Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy — Completed
• DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects — Completed
• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
• Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up — Completed
• Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants — Completed
• Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
• A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 — Stopped early
• Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• BRAVO: Background Regimen of Raltegravir on Virologic Outcome — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed
• Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults — Completed
• Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults — Completed
• Study on Immunopathogenesis in HIV and Hepatitis C Coinfection — Completed
• Study of Bone Disease in Older HIV-infected Adults — Completed